Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Tianli Cheng"'
Autor:
Jialin Su, Shuhua Tan, Houwu Gong, Yongzhong Luo, Tianli Cheng, Hua Yang, Xiaoping Wen, Zhou Jiang, Yuning Li, Lemeng Zhang
Publikováno v:
Global Medical Genetics, Vol 10, Iss 04, Pp 285-300 (2023)
Background The purpose of our study was to construct a prognostic model based on ferroptosis-related gene signature to improve the prognosis prediction of lung squamous carcinoma (LUSC).
Externí odkaz:
https://doaj.org/article/123a8cdcbf2c44639be61508c70bf746
Autor:
Zhou Jiang, Kai Li, Yongzhong Luo, Bin Chen, Fanfan Meng, Huifang Yi, Lemeng Zhang, Hua Yang, Wenwei Zhou, Tianli Cheng, Huihuang Yi, Qing Yi, Xiaoping Wen, Sheng Hu, Hongyan Liu, Jianhua Chen
Publikováno v:
Cancer Nanotechnology, Vol 13, Iss 1, Pp 1-13 (2022)
Abstract Background Targeted delivery of chemotherapeutic drugs to tumour cells is a major challenge for cancer chemotherapy. Recent studies show that tumour cell-derived microparticles can be used as vectors to package chemotherapeutic drugs, and se
Externí odkaz:
https://doaj.org/article/6e8dd7a206754f15926437909e53cb68
Publikováno v:
Cancer Communications, Vol 41, Iss 12, Pp 1331-1353 (2021)
Abstract Patient‐derived cancer cells (PDCs) and patient‐derived xenografts (PDXs) are often used as tumor models, but have many shortcomings. PDCs not only lack diversity in terms of cell type, spatial organization, and microenvironment but also
Externí odkaz:
https://doaj.org/article/da6a560e355d454c971fc878253a2f99
Publikováno v:
Thoracic Cancer, Vol 12, Iss 17, Pp 2307-2313 (2021)
Abstract Background Lung cancer is one of the most common malignant tumors threatening human health. The aim of this study was to investigate the function of miR‐21‐5p in lung cancer progression. Methods We analyzed the expression levels of miR
Externí odkaz:
https://doaj.org/article/509e255c697949d28fa9aca7fa848f68
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-12 (2019)
Abstract Menstrual blood-derived stem cells (MenSCs) have great potential in the treatment of various diseases. As a novel type of mesenchymal stem cells (MSCs), MenSCs have attracted more interest due to their therapeutic effects in both animal mode
Externí odkaz:
https://doaj.org/article/58ecac65326841f2b6ac42e26a650b77
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Immune checkpoint inhibitors (ICIs) significantly improve the survival of patients with non-small-cell lung cancer (NSCLC), but only some patients obtain clinical benefits. Predictive biomarkers for ICIs can accurately identify people who will benefi
Externí odkaz:
https://doaj.org/article/25c7b3200cfd4757a06c1e04541be10c
Autor:
Zhou Jiang, Yongzhong Luo, Lemeng Zhang, Haitao Li, Changqie Pan, Hua Yang, Tianli Cheng, Jianhua Chen
Publikováno v:
Cancers, Vol 14, Iss 15, p 3727 (2022)
Background: The role of lactate acid in tumor progression was well proved. Recently, it was found that lactate acid accumulation induced an immunosuppressive microenvironment. However, these results were based on a single gene and it was unclear that
Externí odkaz:
https://doaj.org/article/cbae41f7ba274e258aee337ac57c06c1
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
The use of programmed cell-death protein 1 (PD-1)/programmed cell-death ligand 1 (PD-L1) inhibitors is the standard therapy for the first-line or second-line treatment of patients with non-small-cell lung cancer (NSCLC). In contrast to current tradit
Externí odkaz:
https://doaj.org/article/e9cecbb6e51e4e19b9346744db780f0c
Autor:
Lemeng Zhang, Yongzhong Luo, Jianhua Chen, Tianli Cheng, Hua Yang, Changqie Pan, Haitao Li, Zhou Jiang
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2021 (2021)
Journal of Oncology, Vol 2021 (2021)
Introduction. The purpose of this study was to explore the efficacy and safety of afatinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations based on real-world evidence. Materials and Meth
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 17, Pp 2307-2313 (2021)
Thoracic Cancer, Vol 12, Iss 17, Pp 2307-2313 (2021)
Background Lung cancer is one of the most common malignant tumors threatening human health. The aim of this study was to investigate the function of miR‐21‐5p in lung cancer progression. Methods We analyzed the expression levels of miR‐21‐5p